The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women

Journal of the Neurological Sciences

Volumn 315, Issue 1-2, 2012, Pages 129-132

  Anziska, Yaacov ^a   Helzner, Elizabeth P ^b   Crystal, Howard ^a   Glesby, Marshall J ^c   Plankey, Michael ^d   Weber, Kathleen ^e   Golub, Elizabeth ^f   Burian, Pamela ^g  

^a Downstate Health Sciences University   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Stroger Hospital   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

African Americans; Diabetes; Gender; Hepatitis C; HIV associated sensory polyneuropathy; Race; Women

Indexed keywords

DIDANOSINE; STAVUDINE; ZALCITABINE;

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENDER; HEPATITIS C; HISPANIC; HIV DISTAL SENSORY POLYNEUROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MIXED INFECTION; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK FACTOR; UNITED STATES; VIRUS LOAD;

ADULT; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; POLYNEUROPATHIES; PROSPECTIVE STUDIES;

EID: 84857995553     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.11.009     Document Type: Article

References (19)

1. Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol 2010;67(5):532-8.
2. Petersen JA, Power C. Sensory neuropathy in human immunodeficiency virus/ acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 2006;59:816-24. (Pubitemid 43673159)
3. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607-13. (Pubitemid 29075612)
4. Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, et al. Manhattan HIV Brain Bank. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004;61(4):546-51. (Pubitemid 38923745)
5. Lichtenstein KA, Holmberg SD, and the HIV Outpatient Study Investigators. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. CID 2005;40:148-57. (Pubitemid 40053473)
6. Maritz J, Benatar M, Dave JA, Harrison TB, Badri M, Levitt NS, et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 2010;41:599-606.
7. Ances BM, Vaida F, Rosario D, Marquie-Beck J, Ellis RJ, Simpson DM, et al. CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Metabolic Study Group. Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS 2009;23:2317-22.
8. Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Price P, et al. Age and height predict neuropathy in patients with HIV-prescribed stavudine. Neurology 2009;73:315-20.
9. Lopez OL, Weiss J, Sanchez J, Dew MA, Becker JT. Neurological characteristics of HIV-infectedmen and women seeking primarymedical care. Eur J Neurol 1999;6:205-9. (Pubitemid 29141902)
10. Cases of HIV infection and AIDS in the United States and dependent areas in 2006 HIV/surveillance report, Volume 18; 2008. Table 5A.
11. Smyth K, Cherry CL. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia, 1993-2006. HIV Med 2007;8:367-73. (Pubitemid 47163268)
12. Barkan SE, Melnick SL, Preston-Martin S, and the WIHS Collaborative Study Group. The Women's Interagency HIV Study. Epidemiol 1998;9:117-25. (Pubitemid 28157608)
13. Bacon M, von Wyl V, Alden C. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005;12(9):1013-9. (Pubitemid 41324530)
14. Hessol NA, Weber KM, Holman S, Robison E, Goparaju L, Alden CB, et al. Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. J Women's Health 2009;18(10):1627-37.
15. Evans SR, Ellis RJ, Chen H, Yeh T, Lee AJ, Schifitto G, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 2011;25:919-28.
16. Wadley AL, Cherry CL, Price P. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symp Manag 2011;41(4):700-6.
17. Marra CM, Boutin P, Collier AC. Screening for distal sensory polyneuropathy in HIV-infected persons in research and clinical settings. Neurology 1998;51(6):1678-81. (Pubitemid 28565252)
18. Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 2008;64(5):566-72.
19. Cherry S, Wesslingh S, Lal L, McArthur J. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 2005;65:1778-81.